Literature DB >> 33152910

Protective effect and mechanism of Qishiwei Zhenzhu pills on cerebral ischemia-reperfusion injury via blood-brain barrier and metabonomics.

Min Xu1, Ruixia Wu1, Yuan Liang1, Ke Fu1, You Zhou1, Xiaoli Li1, Lei Wu1, Zhang Wang2.   

Abstract

Stroke is an acute cerebrovascular disease caused by the sudden rupture of cerebral blood vessels or vascular obstruction from brain tissue damage or dysfunction, thereby preventing blood flow into the brain. Cerebral ischemia-reperfusion injury (CI/RI), a common syndrome of ischemic stroke, is a complex pathological process whose physiological mechanism is still unclear. Qishiwei Zhenzhu pills (QSW), a famous Tibetan medicine preparation, has the effect of tranquilizing by heavy settling, dredging channels and activating collaterals, harmonizing Qi and blood, restoring consciousness, and inducing resuscitation. Here, we investigated the protective effect of QSW on CI/RI in rats and its potential mechanism. First, the volatile and liposoluble components in QSW were determined using gas chromatography-mass spectrometry (GCMS). After 24 h of CI/RI, the neuroprotective effect was determined by evaluating the neurological function, cerebral infarction, histopathology, and blood-brain barrier (BBB) function. Immunofluorescence, real-time quantitative PCR (RT-qPCR), and western blot (WB) were used to detect the expression of matrix metalloproteinase 9 (MMP-9), claudin-5, and occludin. Finally, GCMS metabonomics was used to identify different metabolites and analyze metabolic pathways. The results showed that 88 volatile components and 63 liposoluble components were detected in QSW. Following the experimental stroke operation, it was observed that rats administered QSW pretreatment had improved neurological function, reduced infarct volume (P < 0.01), increased Nissl bodies (P < 0.05), improved histopathology, and reduced BBB disruption. Immunofluorescence, RT-qPCR, and WB results showed that MMP-9 level in the brain tissue of the QSW pretreatment group had a decreasing trend and the expression of claudin-5 and occludin had a tendency to increase. Eleven metabolites related to lipid metabolism, fatty acid metabolism, and energy metabolism, were identified via GC-MS metabonomics. Our study shows that QSW preconditioning has a neuroprotective effect on CI/RI; however, its mechanism requires further study.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Blood-brain barrier; Cerebral ischemia-reperfusion injury; Gas chromatography-mass spectrometry; Neuroprotective effect; Qishiwei Zhenzhu pills

Mesh:

Substances:

Year:  2020        PMID: 33152910     DOI: 10.1016/j.biopha.2020.110723

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  23-Hydroxytormentic acid reduces cerebral ischemia/reperfusion damage in rats through anti-apoptotic, antioxidant, and anti-inflammatory mechanisms.

Authors:  Yamin Wang; Fengrong Liu; Peng Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-04       Impact factor: 3.000

2.  Ginsenoside Rg1 attenuates cerebral ischemia-reperfusion injury due to inhibition of NOX2-mediated calcium homeostasis dysregulation in mice.

Authors:  Yuli Han; Xuewang Li; Liu Yang; Duoduo Zhang; Lan Li; Xianan Dong; Yan Li; Sen Qun; Weizu Li
Journal:  J Ginseng Res       Date:  2021-08-10       Impact factor: 5.735

3.  The Absorption, Distribution, and Excretion of 18 Elements of Tibetan Medicine Qishiwei Zhenzhu Pills in Rats with Cerebral Ischemia.

Authors:  Yinglian Song; Ke Fu; Dewei Zhang; Min Xu; Ruixia Wu; Xueqing Xiong; Xianwu Liu; Lei Wu; Ya Guo; You Zhou; Xiaoli Li; Zhang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-28       Impact factor: 2.629

Review 4.  Current research progress of isoflurane in cerebral ischemia/reperfusion injury: a narrative review.

Authors:  Shu-Jun Chen; Xia-Qing Yuan; Qun Xue; Hai-Feng Lu; Gang Chen
Journal:  Med Gas Res       Date:  2022 Jul-Sep

Review 5.  Mercury and Mercury-Containing Preparations: History of Use, Clinical Applications, Pharmacology, Toxicology, and Pharmacokinetics in Traditional Chinese Medicine.

Authors:  Meiling Zhao; Yi Li; Zhang Wang
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

6.  GC-MS Profile of Hua-Feng-Dan and RNA-Seq Analysis of Induced Adaptive Responses in the Liver.

Authors:  Jia-Jia Liu; Yan Liang; Ya Zhang; Rui-Xia Wu; Ying-Lian Song; Feng Zhang; Jing-Shan Shi; Jie Liu; Shang-Fu Xu; Zhang Wang
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

7.  Zuotai (β-HgS)-containing 70 Wei Zhen-Zhu-Wan differs from mercury chloride and methylmercury on hepatic cytochrome P450 in mice.

Authors:  Yu Nie; Shang-Fu Xu; Yan-Liu Lu; Xiu-Rong Zhao; Cen Li; Li-Xin Wei; Jie Liu
Journal:  F1000Res       Date:  2021-03-11

8.  Determination of 18 Trace Elements in 10 Batches of the Tibetan Medicine Qishiwei Zhenzhu Pills by Direct Inductively Coupled Plasma-Mass Spectrometry.

Authors:  Ke Fu; Yinglian Song; Dewei Zhang; Min Xu; Ruixia Wu; Xueqing Xiong; Xianwu Liu; Lei Wu; Ya Guo; You Zhou; Xiaoli Li; Zhang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-13       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.